Page last updated: 2024-08-22

floxacillin and daptomycin

floxacillin has been researched along with daptomycin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	3 (50.00)	2.80

Authors

Authors	Studies
Becker-Lienau, J; Czihal, M; Hoffmann, U; Rademacher, A; Reiser, MF; Treitl, M	1
Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D	1
Andreoni, F; Eberl, L; François, P; Kalawong, R; Mairpady Shambat, S; Menzi, C; Toyofuku, M; Zinkernagel, AS	1
Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE	1
Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J	1
Falla, E; Mantopoulos, T; Nathwani, D; Vlachaki, I; Zinzi, D	1

Reviews

1 review(s) available for floxacillin and daptomycin

Article	Year
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant Postgraduate medical journal, 2022, Volume: 98, Issue:1155 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin	2022

Trials

2 trial(s) available for floxacillin and daptomycin

Article	Year
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials, 2016, Mar-31, Volume: 17 Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin	2016
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. JAMA, 2020, 02-11, Volume: 323, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin	2020

Article

Year

CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.

Trials, 2016, Mar-31, Volume: 17

Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin

2016

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.

JAMA, 2020, 02-11, Volume: 323, Issue:6

Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin

2020

Other Studies

3 other study(ies) available for floxacillin and daptomycin

Article	Year
Successful antibiotic treatment of severe staphylococcal infection of a long stent graft in the superficial femoral artery with graft preservation in the long term. Cardiovascular and interventional radiology, 2011, Volume: 34, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Arterial Occlusive Diseases; Daptomycin; Drug Therapy, Combination; Femoral Artery; Floxacillin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prosthesis-Related Infections; Radiography, Interventional; Staphylococcal Infections; Stents; Ultrasonography	2011
Antibiotics Stimulate Formation of Vesicles in Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2 Topics: Anti-Bacterial Agents; Bacteriophages; Ceftaroline; Cephalosporins; Cytoplasmic Vesicles; Daptomycin; DNA, Bacterial; Floxacillin; Humans; Lysogeny; Peptidoglycan; Staphylococcus aureus	2019
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective. The European journal of health economics : HEPAC : health economics in prevention and care, 2022, Volume: 23, Issue:8 Topics: Anti-Bacterial Agents; Daptomycin; Floxacillin; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Quality of Life; State Medicine; Teicoplanin; Vancomycin	2022